DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Glufosfamide is an investigational drug.
There have been 9 clinical trials for Glufosfamide. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2013.
The most common disease conditions in clinical trials are Pancreatic Neoplasms, Lung Neoplasms, and Neoplasms. The leading clinical trial sponsors are Threshold Pharmaceuticals, Eleison Pharmaceuticals LLC., and European Organisation for Research and Treatment of Cancer - EORTC.
Recent Clinical Trials for Glufosfamide
|Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer||Eleison Pharmaceuticals LLC.||Phase 3|
|Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma||Threshold Pharmaceuticals||Phase 2|
|Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma||Eleison Pharmaceuticals LLC.||Phase 2|